BE'ER SHEVA, ISRAEL and
BOSTON, Feb. 19, 2018 /PRNewswire/ -- Morphisec, the
leader in Moving Target Defense, today announced it has raised
$12 million Series B round of
funding. The round features new investor Orange Digital Ventures,
the digital investment arm of Orange (Euronext Paris: ORA, NYSE:
ORAN), as well as existing Morphisec investors Jerusalem Venture
Partners ("JVP"), GE (NYSE: GE) and Deutsche Telekom (XETRA:
DTE).
Additional investors in Morphisec include La Maison, Portage
Partners, OurCrowd, Kodem Growth Partners and Evolution Equity
Partners.
Morphisec's patented Moving Target Defense innovation is the
foundation of its Endpoint Threat Prevention solution, which
quickly and simply prevents advanced threats for customers of all
sizes globally.
Morphisec's entirely new approach to endpoint protection makes
it the only solution that can protect during major operating system
patching gaps (like those necessary based on the Spectre and
Meltdown exploits), against zero-day attacks (e.g., WannaCry),
fileless malware and more, all while providing significant
operational and business benefits, including continuity across
patch cycles without the need for updates, zero false positives and
no performance degradation. Morphisec supports endpoints and
servers in physical, VDI and hybrid environments.
"Morphisec is successfully building a rapidly growing customer
portfolio based on its truly unique prevention-based approach. We
are thrilled to support the Morphisec team in their acceleration
and global reach to fundamentally change cyber protection," said
Yann Kandelman, head of Investment
at Orange Digital Ventures.
"Now is the time to invest in cybersecurity technology that is
poised to dramatically hamper attackers' ability to operate and to
enable organizations to succeed in eliminating advanced threats,"
said Yoav Tzruya, JVP General Partner, and Chairman, Board of
Directors, Morphisec. "As threats increase in scale and severity,
alternative technologies don't fully solve the challenges, further
increase direct costs and are unable to fend off business
continuity issues caused by zero-day threats. Our belief is that
Morphisec is well-positioned to become the most critical protective
layer in today's rapidly evolving security stack."
Morphisec's continued growth has been substantial, having
achieved over 1000% growth in 2017, with its technology deployed on
hundreds of thousands of endpoints. The company announced its
Series A funding round in 2015, was named a Gartner Cool Vendor in
2016 and was recognized in 2017 by SE Labs with a 100% efficacy
performance rate against every attack (evasive malware and
exploits) detonated in the lab.
"We built Morphisec to become an essential part of every
company's security and IT operation, and to defeat attacks that
other endpoint technology cannot," said Ronen Yehoshua, CEO and president, Morphisec.
"Our growth has been exponential and this funding will help
Morphisec continue on that trajectory. We continue to grow our
customer list, our partner ecosystem and our headcount so we can
deliver the most groundbreaking technology advancements in a
powerful and simple product that prevents advanced threats and
exploits like no other."
About Morphisec
Morphisec offers an entirely new level
of innovation to customers in its Endpoint Threat Prevention
product, delivering protection against the most advanced
cyberattacks. The company's patented Moving Target Defense
technology prevents threats others can't, including APTs,
zero-days, ransomware, evasive fileless attacks and web-borne
exploits. Morphisec provides a crucial, small-footprint
memory-defense layer that easily deploys into a company's existing
security infrastructure to form a simple, highly effective,
cost-efficient prevention stack that is truly disruptive to today's
existing cybersecurity model.
For more information, please visit www.morphisec.com.
Morphisec Contact:
Tom Bain
Tom.bain@morphisec.com
617-256-3139
Emily Eldridge
morphisec@shiftcomm.com
512-792-2544
View original content with
multimedia:http://www.prnewswire.com/news-releases/morphisec-announces-12m-series-b-funding-round-300600342.html
SOURCE Morphisec